SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001583648-22-000050
Filing Date
2022-06-24
Accepted
2022-06-24 19:03:03
Documents
3
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165611176500631.html 4  
1 FORM 4 wf-form4_165611176500631.xml 4 3984
2 POA (CHRIS KIRITSY HTM) pieris-section16poachris.htm EX-24 4007
3 POA (CHRISTOPHER KIRITSY JPG) pieris-section16poachris001.jpg GRAPHIC 207090
  Complete submission text file 0001583648-22-000050.txt   294711
Mailing Address
Business Address
KIRITSY CHRISTOPHER P (Reporting) CIK: 0001261156 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 221041311

Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations